LivaNova(LIVN) - 2023 Q2 - Earnings Call Presentation

Kits used for cardiac procedures grew year over year, offset by respiratory case declines and product mix. | --- | --- | --- | --- | |---------------------------------------------------------------------|-------|---------|----------| | Adjusted Free Cash Flow Reconciliation ($M) 1Q 2023 | | 2Q 2023 | 2023 YTD | | Net cash provided by operating activities |$20.8 | $(17.9) |$2.8 | | Less: Purchases of plant, property and equipment (7.7) (5.7) (13.3) | | | | | Less: Cash received from tax stimulus (9.9) — (9 ...